Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
| ▸ | GABRD | O14764 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.34 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.34 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.34 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL290459 | 0.96 | LMNA (0.46) | TSHRSLC22A6LMNANFKB1PMP22 | |
| Ethylene Glycol SCHEMBL6523934 | 0.94 | TSHR (0.44) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL905720 | 0.94 | TSHR (0.48) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL905699 | 0.94 | TSHR (0.48) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL905402 | 0.94 | TSHR (0.48) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL379359 | 0.94 | TSHR (0.48) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL1870547 | 0.94 | TSHR (0.48) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL1230057 | 0.94 | TSHR (0.48) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL2593466 | 0.91 | TSHR (0.41) | TSHRSLC22A6LMNANFKB1PMP22 | |
| SCHEMBL43574 | 0.89 | EGLN1 (0.43) | TSHRSLC22A6LMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2200 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108634-A1 | HIGH MOLECULAR WEIGHT MULTI-ARM POLYMERS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-04-23 | — | — | US | claimed |
| EP-4724117-A2 | METHOD OF TREATING AN ARTICULAR CONDITION OR A CONDITION OF A BONY CANAL | Ocular Therapeutix, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-12599624-B2 | Biodegradable lung sealants | ETHICON, INC. (US) | 2026-04-14 | — | — | US | claimed |
| US-12600825-B2 | Polymer compositions and biosurfaces comprising them on sensors | ZEPTO LIFE TECHNOLOGY, INC. (US) | 2026-04-14 | — | — | US | claimed |
| EP-4580690-B1 | BIODEGRADABLE LUNG SEALANTS | ETHICON INC (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4704930-A1 | COMPOSITIONS AND RELATED METHODS | Boston Scientific Scimed, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260061090-A1 | MEDICAL TISSUE ADHESIVE FOR PANCREATIC PLUGGING AND PREPARATION METHOD AND USE THEREOF | BEIJING BIOSIS HEALING BIOLOGICAL TECH CO LTD (CN) | 2026-03-05 | — | — | US | claimed |
| US-20260049177-A1 | PREPOLYMERS AND COMBINATIONS THEREWITH FOR WOUND REGENERATION | Sunnybrook Research Institute (US) | 2026-02-19 | — | — | US | claimed |
| EP-4291256-B1 | TWO COMPONENT SEALING SYSTEMS INCLUDING SYNTHETIC MATRICES AND BIOSYNTHETIC ADHESIVES | ETHICON INC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-3600189-B1 | SKIN CLOSURE SYSTEMS AND DEVICES OF IMPROVED FLEXIBILITY AND STRETCHABILITY FOR BENDABLE JOINTS | ETHICON INC (US) | 2026-02-18 | — | — | EP | claimed |
| US-20040023842-A1 | Biocompatible crosslinked polymers | INCEPT | 2004-02-05 | — | — | US | claimed |
| EP-1318827-A1 | POLYMER-MODIFIED SYNTHETIC PROTEINS | Gryphon Therapeutics, Inc. (US) | 2003-06-18 | — | — | EP | claimed |
| US-6555656-B2 | Covalent modification of abnormal prion protein | ALBANY MEDICAL COLLEGE | 2003-04-29 | — | — | US | claimed |
| US-6524586-B2 | Enhancement of oligomeric viral immunogenicity | ALBANY MEDICAL COLLEGE | 2003-02-25 | — | — | US | claimed |
| US-20020173029-A1 | Covalent modification of surface protein or carbohydrate | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-11-21 | — | — | US | claimed |
| US-20020172977-A1 | Covalent modification of abnormal prion protein | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-11-21 | — | — | US | claimed |
| US-20020172689-A1 | Enhancement of oligomeric viral immunogenicity | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2002-11-21 | — | — | US | claimed |
| WO-2002020033-A1 | POLYMER-MODIFIED SYNTHETIC PROTEINS | GRYPHON THERAPEUTICS, INC. (US) | 2002-03-14 | — | — | WO | claimed |
| US-5908624-A | Antigenic modulation of cells | ALBANY MEDICAL COLLEGE (US) | 1999-06-01 | — | — | US | claimed |
| WO-1999000145-A9 | ANTIGENIC MODULATION OF VIRAL PARTICULES | ALBANY MEDICAL COLLEGE (US) | 1999-04-15 | — | — | WO | claimed |